• • Domiciliary non-invasive ventilation may aid survival in chronic obstructive pulmonary disease, but evidence pertaining to improvement in quality of life is inconsistent and could be a barrier to use in palliative care.
Introduction
Non-invasive ventilation (NIV) is used to treat type 2 respiratory failure and can be used acutely in hospital, 1 where it has clear benefits, or at home, where use is increasing as NIV machines have become cheaper and easier to use 2 but the case for use is less clear. In chronic domiciliary use for chronic obstructive pulmonary disease (COPD), some studies have shown benefits on mortality 3, 4 and admission rate, 5 but this is not consistent. A recent Cochrane review showed no significant difference in quality of life (QOL) when used in such patients, and few other clinically significant benefits. 6 In the United Kingdom, 11% of hospitalised COPD patients require NIV acutely; 7 some may be unable to wean from NIV and thus require domiciliary use. 8, 9 Domiciliary NIV may also be started to prevent recurrent admissions, 9 or in palliative care of patients with chronic respiratory failure. 10 Palliative care for COPD is a recognised area of unmet need, 11 and very few qualitative studies exploring treatments used at this stage have been conducted. One of the larger NIV trials demonstrated improved short-term survival but decreased QOL; 12 this could occur because NIV is seen as inconvenient, uncomfortable or noisy. Given the inconsistent evidence from questionnaires used in trials, we chose a qualitative study design, aiming to examine the processes and experiences surrounding starting and managing NIV from the perspective of healthcare professionals (HCPs) and COPD patients with a view to designing future services capable of aiding patient tolerance/adherence and reducing any impairment in QOL.
Methods

Study design and ethical considerations
A qualitative interview study, approved by local ethics committee (11/WM/0422), was conducted over a 4-month period in 2012. Written informed consent was taken from participants; 1 of 22 patients approached refused to consent, and none withdrew consent. One patient was excluded as their treatment was found to be continuous positive airway pressureand and not NIV. The remaining participants were HCPs or carers of the patients.
Recruitment and sampling
Participants were recruited using purposive sampling. We aimed to conduct 30 interviews, as prior experience has shown this sufficient to gain meaningful insights in applied qualitative health research, but this was later expanded to address emerging themes in the data. Patients were identified by clinical teams. Inclusion criteria were as follows: COPD, past or current use of domiciliary NIV or at least two episodes of acute NIV use. The latter group was chosen as potential future domiciliary NIV users. 13 Exclusion criteria included clinical instability or lack of mental capacity. All patients were told they could invite a carer to be interviewed; this was done to gain perspective on the contributions of carers to delivery of NIV and ascertain whether patients felt their carers' input was necessary to continue use. HCPs were recruited if they had experience of initiating or managing acute or domiciliary NIV in COPD patients. The interviewer (M.J.), a female medical student, was not known to participants prior to the study, had qualitative interview technique training as part of her research degree and was mentored by N.K.G. and A.M.T. during the process.
Data collection
Audio-recorded, face-to-face qualitative interviews were conducted in the interviewees' preferred location (patients'/ carers' homes or at a hospital) by M.J. Interview schedules were prepared in advance by M.J., N.K.G. (medical sociologist) and A.M.T. (consultant respiratory physician), covering general views on NIV, decision-making processes to commence domiciliary NIV and experiences of long-term NIV use (supplementary data). Field notes were taken during interviews to aid subsequent interpretation.
All patients also consented to data collection from their hospital records. This was done to improve transferability 14 of findings and gauge the typicality of participants. Direct questioning established Medical Research Council dyspnoea and Lawton Instrumental Activities of Daily living scores. 15 No follow-up interviews were conducted and there was no participant input to transcription/correction of recordings.
Analysis
Interviews were transcribed verbatim and analysed descriptively using conventional (inductive) qualitative content analysis 16 (Figure 1 ). Open coding was applied to transcripts, line-by-line, independently by both N.K.G. and M.J. without the aid of qualitative data analysis software. Inductive codes were created for patient interviews while both inductive and deductive codes were used to analyse HCP interviews. A descriptive coding framework was developed and agreed; concepts were grouped and Implications for practice, theory or policy • • Service designs that better facilitate adaptation through education and practical support could aid use of domiciliary noninvasive ventilation in palliative care. summarised in a matrix using the framework method. 17 Descriptive themes were developed from the data and deviant cases identified. Subsequent interpretive thematic analysis, based on constructivist grounded theory, was conducted focusing on 'social actions'. 18 The central substantive theory that was developed and is described herein was 'adapting to domiciliary NIV'. Key findings are reported with illustrative quotes using anonymous identifiers: HCPs [HCP#], patients [P#] and carers [C#]. The above codes were used during analysis of patient (and carer) transcripts and HCPs, respectively. Several types were used including 'in-vivo', attribute, emotions, values, description or magnitude codes, the aim being to highlight a range of issues identified in the transcripts, allow meanings to develop and to be attached to the data. From these, the major and minor themes listed in Table 2 emerged.
Results
Participant characteristics
In all, 39 participants were recruited from two hospitals in Birmingham, UK. Characteristics of the patients (n = 20) are shown in Table 1 ; 12 were chronic users of home NIV, 3 past users and 5 recurrent acute users. Patients had very severe symptomatic COPD, a high burden of COPDrelated co-morbidities and high disability scores. Two past users stopped due to intolerance, one due to receipt of a lung transplant. The data concurred with the literature showing the negative impact of COPD on patients' lives. 19 Five patients lived alone with no daily carer; four had current daily carers (three spouses and one sibling) who agreed to interview; no other carers were willing/able to be interviewed. Carers were similar in age to patients, were generally well with few active health problems and no significant disability and shared patients' views of COPD. All patients and carers were White British or Irish.
The 15 HCPs recruited comprised 7 doctors, 4 specialist nurses, 2 physiotherapists and 2 physiologists. HCPs were aged 26-54 years and were predominantly UK born and educated, with a range of ethnicities. There were no notable differences in the themes emerging from different HCP types. Interview duration averaged 40 min (range 19-68 min).
Negotiating domiciliary NIV use
Decisions regarding domiciliary NIV were reportedly based on unclear clinical evidence, influenced by past experiences and individual negotiations. The social actions undertaken to assess whether a patient was offered domiciliary NIV and was likely to 'comply', as well as actions that patients took to decide whether they accepted and continued it have been categorised into four themes: clinical, technical, socio-economic and experiential. Table 2 provides a list of social actions (gerunds) identified in the analysis, grouped thematically, and provides illustrative quotes. It demonstrates clearly where views and experiences of HCPs and patients contrasted. Table 3 shows areas that emerged from the analysis that could be the focus of future care redesign. All themes contributed to the evidence pertaining to patient selection; technical and experiential themes were informative regarding mechanisms to improve tolerance/adherence and the socio-economic theme informed suggestions about health service designs supporting NIV use.
Clinical domain
The focus for HCPs was addressing clinical indications and improving outcomes. They felt limited by the absence of clear evidence on measurable benefits (e.g. hospital admissions, mortality), thus selected for treatment on a case-by-case basis. They described the importance of taking time to convey the purpose of NIV to patients, to promote patient choice and to support compliance. HCPs tended to stress that the decision was ultimately the patients'; conversely, patients felt they had no choice about whether or not to accept domiciliary NIV, relying on their doctors' recommendations, believing they would act in their best interests. Nevertheless, many patients linked their acceptance of NIV with wanting to extend life and improve QOL.
QOL. HCPs acknowledged that they struggled with the potential for NIV to impair QOL and balancing this with uncertainty of clinical effectiveness:
If someone is really terminal COPD are you really going to do them any good by sticking them on a machine which might make their quality of life worse and they will probably die anyway whether you give them NIV or not. So the patient selection should be looked at very well before we start it on everyone [HCP #12].
Patients, however, were almost unanimous in their view that QOL improved with the use of home NIV, stating 'it has given me quality of life' [Pt #8]; 'It's done me proud' [Pt #1]; 'It's done me the world of good' [Pt #6]; 'It might be because of this machine I haven't been so ill' [Pt #10] and 'It has helped me and I am grateful of it' [Pt #19]. One patient was convinced that NIV was the reason she was alive; 'it was beneficial to me; it kept me going for 10 years … that was quite an achievement' [Pt #1]. Many patients while acknowledging the medical purpose of NIV, to 'get the carbon dioxide out of the system' [Pt #10] and 'open up all the airways' [Pt #17], were also able to delineate specific symptomatic benefits. Patients experienced improvements in breathlessness, 'it helps me breath' [Pt #8] and in their general well-being, 'gives me a bit more energy' [Pt #1]. Patients also conveyed that NIV was helping them carry out their activities of daily living 'to do more' and 'get around more' [Pt #10]. Ultimately, this helped them to 'give me back a normal life … to get me back to a normal existence' [Pt #1]. Carers also shared the same thoughts, revealing how they thought again it was 'a God-send' [C #8].
Socio-economic domain
Challenges of maintaining equitable care due to social deprivation were raised (e.g. failure to engage due to transport costs) as well as the potential for primary care involvement to improve management ( Table 2) . Some did not focus on equity, but felt it important to ensure that resources were not wasted. Generally, HCPs considered it cost-effective. People with COPD acknowledged their dependence on family and friends. They valued high-quality information Assessing the level of information and support given to them by clinicians 'No they didn't give me enough information … they didn't … say this machine does this, this machine will do that, this will help you feel this way and I think they need to do that to make people feel more confident in having the machine' (P9) 'I think a lot of it is the symptomatic improvement the patient gets, including quality of sleep and perceived reduction in dyspnoea'. (HCP6) Balancing extending life with quality of life 'even if you can slightly offset that deterioration in quality of life, that is a very valid thing to do' (HCP3) 'if someone is really terminal COPD are you really going to do them any good by sticking them on a machine which might make their quality of life worse' (HCP12) Experimenting with tolerance case-by-case 'give it to them, see whether it benefits them. .. reassess them in 3 months' time … re-do their investigations, bloods, spirometry … see how much improvement and then ask them whether they feel improved' (HCP5) Acknowledging risk of dependence 'it does make them feel so much better, and then you get an over reliance on it, so when they come off it they're feeling that they are getting short of breath, panic tends to set in … feel they need to go back on it again' (HCP8) Evaluating patient's personality 'it depends on the patient's personality as well, whether they will cope with it, intelligence as well … more positive people … willing to give things a try' and support and were critical where gaps were left. A few patients acknowledged financial restrictions, citing feelings of guilt when they had to ask for replacement masks, but resisted if perceived unfair.
Socio-economic
Role of carers and the home environment. For HCPs assessing the patients' social situation was crucial; poor support led to concerns regarding NIV compliance and therefore subsequent efficacy. They assessed whether 'the home set up is appropriate for it [NIV]' [HCP #2] as those with 'very supportive family sometimes I think they have the best outcome' [HCP #5]. Adaptation to NIV was not an individual experience, but extended beyond to patient's families. Patients developed an increased reliance on their family for many aspects of their lives due to their disability, such as requiring assistance for routine self-care such as bathing or getting to hospital appointments. The patient's family also became the first port of call for any NIV-related problems, which patients saw as a burden; 'Poor husband has been up and down the hospital I don't know how many times … I told him to go up and get another one and he got it and that wasn't right the poor bloke was traumatised' [Pt #3]. 'There was something wrong with my mask I can't remember what it was and my son had to take it in' [Pt #1]. Carers generally exhibited similar attitudes towards NIV as their partner/sibling; 'we just got used to it … something you've got to put up with' [C #14] again accepting NIV because of the perceived idea that it is essential; 'she does really need it' [C #3].
There were no major differences observed in adaptation processes or patterns between patients with and without carers. Some patients who lived alone felt NIV impaired their ability to form intimate relationships 'You could never have a partner' [Pt #10]; this was acknowledged by one who commented on the way the NIV disturbed his wife's sleep ( Table 2) .
Technical
Patients and HCPs explained that NIV caused a number of problems. The mask was painful and caused facial sores. Dryness in the mouth and skin, noise and claustrophobia were also widely reported. However, patients described feeling that they had to adapt to discomfort, by way of numerous (often partial) technical fixes, such as using moisturiser or plasters on pressure points, alongside accepting discomfort because they 'had to'. This notion of forced adaptation to NIV links to the patients' view that they had no choice over whether to use it. HCPs' accounts emphasised ways in which patients could contact the service for support, rather than day-to-day coping mechanisms.
Experiential
This domain was recognised as vital by both HCPs and patients because it was a determinant of long-term NIV use. The perception of whether NIV was improving QOL, brought symptomatic relief and improved or disturbed sleep was important. There were two deviant cases; one patient exclaimed how he 'hates it' and that it should be given 'to people in prison, they won't go back again' [Pt #12], yet this patient still continues to use it. Another patient who had only used NIV at hospital declared that 'if the King came to me and said you gotta have one, I'd say no' [Pt #20].
Personality was cited by HCPs (ability to cope, acceptance), patients and carers (strength, a positive attitude to life) as an important determinant of success with NIV. Sufficient time to adapt to the treatment was noted to be important, but was highly variable -it ranged from 'a couple of minutes' [Pt #17] for some patients, up to 'months' [Pt #11] for others. The risk of patients becoming dependent, Table 3 . Emerging themes to aid initiation and adaptation to domiciliary NIV in COPD.
HCPs
Patients/carers Clinical Clarity regarding clinical effectiveness Understanding physical effects and potential clinical benefit of NIV Use of multi-modal education -verbal, written and audio-visual clinically or emotionally, was acknowledged by all groups ( Table 2 ).
Discussion
Our data demonstrate that starting and continuing domiciliary NIV requires active negotiation by patients and HCPs and is informed by clinical, socio-economic, technical and experiential forms of 'evidence'. Improved understanding and a critical perspective on these could lead to more effectively targeted interventions to reduce any negative effects on QOL.
Clinical issues, including QOL and patient choice
The most important element for both patients and HCPs was whether domiciliary NIV was clinically effective, and what the risks were if not used. Individual clinicians may choose to weigh the clinical evidence up differently. In one large trial, 144 severe COPD patients were randomised to long-term oxygen therapy (LTOT) with or without NIV; patients on NIV were more likely to survive (hazard ratio (HR) 0.63 (0.40-0.99)); however, this was at the expense of QOL (p = 0.002). 12 A more recent study has confirmed this survival benefit. 4 Conversely, slight improvements in disease-specific QOL have been reported 20, 21 as have lower admission rates. 5, 21 Differences in outcome may have resulted from use of different tools to assess QOL -the 36-Item Short-Form Health survey (SF-36), 12 St Georges Respiratory Questionnaire (SGRQ) 20 and Maugeri Foundation Respiratory Failure Questionnaire (MRF-28), respectively; 20 arguably the latter might be more informative in this highly selected population. Differing NIV protocols may also be relevant; higher pressures may result in more impressive changes in blood gases and lung function, alongside improved QOL. 10 This implies that lack of clinical effect in some studies could simply be due to a suboptimal protocol.
Patients usually described symptomatic relief and improved daily function on NIV, outcomes not reported widely in previous domiciliary NIV trials. Primary outcomes in the largest two trials were severity of hypercapnia 21 and survival, 12 demonstrating HCPs' perception that use of domiciliary NIV should provide measurable clinical improvements rather than 'softer' symptomatic outcomes. Early work has now been carried out, albeit in a different population, to assess the feasibility of NIV for palliative care and has shown promise. 22 This, together with our data, suggests that negativity regarding prior QOL data should be balanced against the potential for this treatment to improve lives.
Honesty about the potential risk and benefits of treatment was perceived as vital before prescribing domiciliary NIV. In most of the accounts, death and its potential proximity were starkly absent, suggesting that discussions about palliative care were limited. Evidence across other chronic diseases suggests that patients value HCPs obtaining their opinion on end-of-life care, although many prefer clinicians to make the final decisions. 23 This applies particularly to older patients with poorer health or a lower socio-economic status, 24 as many of our group were.
Any medical 'choice' a patient makes is limited to the opportunities presented by HCPs unless they actively seek alternatives. Patient choice is an important value 25 cited by HCPs, but COPD patients' accounts show that choices were highly constrained -indeed, many felt NIV was their only option to survive. To manage this lack of choice, patients explained that they trusted their doctors and were committed to extending their lives, even if that required adaptation to the physical and psychological side effects of NIV. This is an example of forced adaptation.
Socio-economic issues, including the role of carers
Health economics was a factor recognised by patients and HCPs; it may be cost-effective in those with recurrent hospital admissions. 13 HCPs described situations where because of a perceived inability to cope, personality type or poor social support, they would not offer patients NIV, implying an inherent risk of inequality in terms of who is offered NIV. Despite this, it was apparent that many patients with no close social support received NIV in our study. Carer involvement has been found essential in patients using NIV for neuromuscular disease, 26 although differences in physical ability to put the machine could reduce the generalisability of this evidence to COPD. Where carers were present, they played a major role in NIV care delivery; however, this is an area in which external care might be provided, as acknowledged by interviewed HCPs ( Table 2) . Inequity might be avoided if greater systemic adaptations to domiciliary NIV were instituted (Table 3) .
Technical issues and adaptive solutions
The necessity to 'get used to' NIV was a central theme. HCPs offered a range of solutions to improve tolerance: technical suggestions about the equipment, educational solutions to improve motivation and radical social changes, such as moving someone to a care home to improve carer support. Patient accounts stressed their acceptance of the need to adapt, even with substantial discomfort or anxiety. The latter may have implications for setting up of NIV, which is often done in hospital. 27 The process of adaptation appeared central for continued NIV use. An important tension was that whereas HCPs stressed access to support, patients often felt the burden of adaptation was theirs and did not discuss issues with their HCPs. Simple measures like leaflets outlining technical solutions may be insufficient -these were often reported by HCPs but rarely remembered by patients. DVDs, video demonstrations posted online or patient-led workshops might be useful alternatives. Ongoing investment in machine or mask comfort will no doubt also help. Despite tolerance issues, our data concurred with previous studies in showing high levels of acceptance of domiciliary NIV by COPD patients. 28 
Experiential issues
Perceptions of usefulness, especially in terms of improved ability to perform the activities of daily living and symptom relief, were important in decision-making, even where clinical explanations for these effects were unclear. These wider types of evidence may be key to managing end-stage COPD, where 'cure' is not achievable.
A number of patients reported bad experiences of acute NIV which influenced their opinion of domiciliary NIV and might be amenable to change. Education about NIV early in disease, so that it comes as less of a shock when admitted acutely, might help. Greater education of acute support staff could aid reassurance. Finally, the setting for starting domiciliary NIV might be changed -hospital commencement has strong support for technical aspects, but psycho-social support is poorer. Home commencement by community nurses could aid adaptation, particularly for fearful patients.
Strengths and limitations
The strength of this study was the range of perspectives collected, across HCP types and geographical areas (two hospitals). We reduced bias by obtaining lists of NIV patients from clinicians from which we purposively sampled eligible participants. However, the sample lacked ethnic diversity; this was reflective of those on NIV but was not reflective of the local population. While we continued recruiting until we felt that no new issues were emerging in the data, we were not able to return after analysis to further explore themes. It, therefore, remains possible that saturation was not achieved, and that the relative lack of number of carers could have biased findings pertinent to this subgroup. It is important to note that this study was not an efficacy study of domiciliary NIV and should not be interpreted as such.
Conclusion
Both patients and HCPs actively negotiate the process of patients' adaptation to NIV, although their experiences and views are not always convergent. Their actions can be understood within the context of clinical, socio-economic, technical and experiential factors. While domiciliary NIV is valued by COPD patients, the process of adaptation could be optimised by HCPs considering broader ways of explaining the process, other settings for initiation and generating more patient-centred data on its benefits.
